MEDIZEN HUMANCARE Inc. (XKON:236340)
South Korea
· Delayed Price · Currency is KRW
2,000.00
+200.00 (11.11%)
At close: Dec 5, 2025
MEDIZEN HUMANCARE Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2014 | FY 2013 |
| Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
| Revenue | 583.88 | 95.39 |
| Revenue Growth (YoY) | 512.09% | - |
| Cost of Revenue | 225.31 | 48.58 |
| Gross Profit | 358.57 | 46.81 |
| Selling, General & Admin | 1,200 | 636.98 |
| Research & Development | 234.67 | 478.88 |
| Other Operating Expenses | 21.69 | 6.82 |
| Operating Expenses | 2,007 | 1,171 |
| Operating Income | -1,648 | -1,124 |
| Interest Expense | -48.4 | -35.31 |
| Interest & Investment Income | 8.91 | 0.24 |
| Other Non Operating Income (Expenses) | 1.69 | -0.07 |
| EBT Excluding Unusual Items | -1,686 | -1,159 |
| Other Unusual Items | - | -0.89 |
| Pretax Income | -1,686 | -1,160 |
| Net Income | -1,686 | -1,160 |
| Net Income to Common | -1,686 | -1,160 |
| Shares Outstanding (Basic) | 2 | 2 |
| Shares Outstanding (Diluted) | 2 | 2 |
| Shares Change (YoY) | 32.09% | - |
| EPS (Basic) | -821.00 | -746.00 |
| EPS (Diluted) | -821.00 | -746.00 |
| Free Cash Flow | -2,233 | -1,302 |
| Free Cash Flow Per Share | -1086.98 | -837.23 |
| Gross Margin | 61.41% | 49.07% |
| Operating Margin | -282.33% | -1178.21% |
| Profit Margin | -288.80% | -1215.99% |
| Free Cash Flow Margin | -382.36% | -1364.69% |
| EBITDA | -1,098 | -889.22 |
| EBITDA Margin | -188.10% | - |
| D&A For EBITDA | 550.16 | 234.68 |
| EBIT | -1,648 | -1,124 |
| EBIT Margin | -282.33% | - |
| Advertising Expenses | 37.43 | 13.46 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.